Literature DB >> 3982061

Effect of prethymectomy plasma exchange on postoperative respiratory function in myasthenia gravis.

G d'Empaire, D C Hoaglin, V P Perlo, H Pontoppidan.   

Abstract

The effect of prethymectomy plasma exchange on postoperative mechanical ventilation requirement and length of stay in the intensive care unit were studied retrospectively in 37 patients with myasthenia gravis. We found a significantly decreased time on mechanical ventilation (mean 1.02 +/- 0.40 versus 3.43 +/- 0.60 days) and a shorter stay in the intensive care unit (mean 3.09 +/- 0.99 versus 5.15 +/- 0.66 days) for 11 patients with respiratory weakness who were treated with preoperative plasma exchange compared with 26 patients who did not receive plasma exchange. Patients with respiratory weakness who received prethymectomy plasma exchange required less time on mechanical ventilation (mean 1.02 +/- 0.40 versus 2.73 +/- 0.88 days) and a shorter stay in the intensive care unit (mean 3.09 +/- 0.99 versus 4.46 +/- 1.08 days) than those patients without respiratory weakness who did not receive plasma exchange. Eleven patients met the criteria for plasma exchange but did not receive it. They required significantly more time on mechanical ventilation (mean 4.43 +/- 0.94 versus 1.02 +/- 0.40 days) and in the intensive care unit (mean 6.09 +/- 0.86 versus 3.09 +/- 0.99 days) than patients who received plasma exchange. Our results indicate that patients with severe forms of myasthenia gravis treated with prethymectomy plasma exchange require less mechanical ventilation and less time in the intensive care unit postoperatively.

Entities:  

Mesh:

Year:  1985        PMID: 3982061

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis.

Authors:  P Rieder; M Louis; P Jolliet; J C Chevrolet
Journal:  Intensive Care Med       Date:  1995-08       Impact factor: 17.440

2.  Combined operation for myasthenia gravis and coronary artery disease.

Authors:  Katsuyuki Asai; Kazuya Suzuki; Naoki Washiyama; Hitoshi Terada; Katsushi Yamashita; Teruhisa Kazui
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-02

3.  Comparative efficacy of low dose, daily versus alternate day plasma exchange in severe myasthenia gravis: a randomised trial.

Authors:  Isha Trikha; Sumit Singh; Vinay Goyal; Garima Shukla; Rama Bhasin; Madhuri Behari
Journal:  J Neurol       Date:  2007-08-11       Impact factor: 4.849

4.  Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis.

Authors:  Josep Gamez; María Salvadó; Francesc Carmona; Miriam de Nadal; Laura Romero; Daniel Ruiz; Alberto Jáuregui; Olga Martínez; Javier Pérez; Pilar Suñé; María Deu
Journal:  Ther Adv Neurol Disord       Date:  2019-07-17       Impact factor: 6.570

Review 5.  Plasma exchange for myasthenia gravis.

Authors:  P Gajdos; S Chevret; K Toyka
Journal:  Cochrane Database Syst Rev       Date:  2002
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.